The neuropathology of Alzheimer's disease (AD) includes amyloid plaque formation by the amyloid b-protein (Ab) and intracellular paired helical filament formation by tau protein.
The most common late-life neurodegenerative disorder is Alzheimer's disease (AD). AD affects an estimated 5.3 million people in the US and 35 million people worldwide (Prince et al. 2013 , Alzheimer's Association 2015 . Unfortunately, no preventive, disease-modifying, or curative therapies currently exist (Cummings et al. 2014) . AD is characterized histopathologically by the cerebral deposition of two hallmark proteinaceous aggregates: extracellular amyloid plaques formed by the amyloid b-protein (Ab) and intracellular neurofibrillary tangles formed by tau protein (Goedert and Spillantini 2006) . Ab is produced through the endoproteolytic processing of the amyloid precursor protein by b-secretase and c-secretase (O'Brien and Wong 2011), which leads to the formation of two predominant Ab alloforms, Ab40 (40 amino acids in length) and Ab42 (42 amino acids in length). Ab42 is more amyloidogenic than Ab40 and is the predominant peptide found in neuritic plaques (Fukumoto et al. 1996) , whereas Ab40 is found in greater abundance in cerebrovascular amyloid (Smith and Greenberg 2009) .
To date, no single test can identify a patient that has or will get AD. Instead, tests generally are used in combination to establish a diagnosis. These tests may include patient history and neuropsychological assessment (e.g., mini-mental status examination), CSF Ab and tau concentrations, brain magnetic resonance imaging, and glucose positron emission tomography (PET) scans. However, even combinatorial testing does not provide a definitive diagnosis of AD (Khan and Alkon 2015) . To improve diagnostic and prognostic capabilities, a number of PET imaging agents have been developed that bind to different amyloids (e.g., Ab or tau) (Rowe and Villemagne 2011; Vlassenko et al. 2012; Mason et al. 2013) . These include [ Flutemetamol (trade name: Vizamyl) (Rowe and Villemagne 2011; Vallabhajosula 2011) . These PET amyloid ligands provide semi-quantitative information about amyloid deposition in patients. Importantly, in some studies, evidence of amyloid deposition provided by these agents presaged the development of clinical symptoms of AD 7-15 years before their occurrence (Jack et al. 2013; Roe et al. 2013 ). This prognostic ability may provide a therapeutic window for secondary disease prevention not currently available.
PiB, a derivative of the fluorescent benzothiazole dye thioflavin T, binds to fibrillar Ab, and thereby allows noninvasive visualization of amyloid deposits in situ (Klunk et al. 2004; Johnson et al. 2009 ). The Alzheimer's Disease Neuroimaging Initiative suggests that PiB is a useful predictor of cognitive decline and brain atrophy in patients with mild cognitive impairment (Weiner et al. 2010) . However, working hypotheses about AD causation in which protofibrillar and oligomeric Ab assemblies are the most important pathologic agents have supplanted those focusing solely on Ab fibrils (Klein et al. 2004; Roychaudhuri et al. 2009; Kirkitadze et al. 2002; Haass and Selkoe 2007) . PET imaging agents that bound these assemblies could have substantial clinical value. For these reasons, we evaluated the ability of PiB to bind Ab protofibrils and oligomers.
Methods

Chemicals and reagents
3
H-PiB, specific activity 72.44 Ci/mmol, and PiB were generously provided by Drs. Chet Mathis and William Klunk (University of Pittsburgh). Myoglobin (from horse skeletal muscle), albumin (chicken egg), insulin chain B (oxidized), and vitamin B12 were purchased from Sigma (Sigma-Aldrich, St. Louis, MO, USA). All solutions were prepared in double-distilled de-ionized (DDI) water produced using a Milli-Q system (Millipore Corp., Bedford, MA, USA).
Synthesis of Ab
Ab was synthesized, purified, and characterized essentially as described previously (Walsh et al. 1997) . Briefly, peptide synthesis was performed on an automated peptide synthesizer (model 433A, Applied Biosystems, Foster City, CA, USA) using 9-fluorenylmethoxycarbonyl-based methods on preloaded Wang resins. Ab was purified to >97%, using reverse-phase high-performance liquid chromatography (HPLC). Quantitative amino acid analysis and mass spectrometry yielded the expected composition and molecular weight. Purified peptides were stored as lyophilizates at À20°C.
Preparation of Ab for study
Ab was prepared by dissolution in 10% (v/v) 60 mM NaOH, 45% (v/v) Milli-Q water, and 45% (v/v) 22.2 mM sodium phosphate, pH 7.5, to yield a nominal Ab concentration of 1 mg/mL in 10 mM sodium phosphate, pH 7.5. The Ab solution then was sonicated for 1 min in a bath sonicator (Branson Model 1510, Danbury, CT, USA) and filtered through a pre-washed 30 000 molecular weight cut-off Microcon centrifugal filter device (Millipore, Billerica, MA, USA) for 15 min at 16 000 g. The eluate containing Ab was quantified using UV absorbance (e 280 = 1280 cm À1 M
À1
), using a 1 cm quartz cuvette (Hellma, Plainview, NY, USA) and a Beckman DU-640 spectrophotometer (Beckman Instruments, Fullerton, CA, USA), prepared with 10 mM sodium phosphate, pH 7.5. All measurements were performed at 22°C.
Preparation of Ab oligomers, protofibrils, and fibrils
Oligomers and protofibrils were prepared according to Teplow et al. (Teplow 2006) . Briefly, oligomers of Ab40 and Ab42 were prepared by dissolving 1 mg of Ab peptide in 100 lL of 60 mM aqueous NaOH, 450 lL of water, and 450 lL of 22.2 mM sodium phosphate buffer, pH 7.5. The resulting solution, 10 mM sodium phosphate buffer, pH 7.5, was sonicated for 1 min in a bath sonicator (Branson Model 1510) and filtered through a pre-washed 30 000 molecular weight cut-off Microcon centrifugal filter device (Millipore) for 15 min at 16 000 g using a bench top centrifuge (model 5145C, Eppendorf, Hamburg, Germany) to remove insoluble material. Transmission electron microscopy (TEM) ( Fig. 1 ) and size exclusion chromatography (SEC) confirmed the presence of oligomers. Oligomer size distributions and purities were also determined using photo-induced cross-linking of unmodified proteins, a zero-length chemical cross-linking method used to stabilize early Ab assembly states, as previously published (Bitan et al. 2003) .
Protofibrils were prepared following the procedure above, but after centrifugation, the supernates were transferred into fresh microcentrifuge tubes and incubated at 37°C for 48 h ([E22G] Ab40) or 3 h ([E22G]Ab42) without agitation. The respective [E22G]Ab solutions then were centrifuged at 16 000 g for 10 min to pellet any fibrils present. The resulting supernates then were filtered through a Microcon centrifugal filter device (molecular mass cut-off of 30 kDa; Millipore, Billerica, MA, USA) to remove oligomers and monomers. The retentates were washed thrice with water and then resuspended in water at a concentration of 10 lM. EM confirmed the presence of protofibrils. The purities of the [E22G]Ab40 and [E22G]Ab42 protofibril preparations, determined using size exclusion chromatography (SEC), were 70% and 84%, respectively.
To prepare Ab40 and Ab42 fibrils, the procedure for preparing oligomers was followed, but after centrifugation, the resulting supernates were transferred into new microcentrifuge tubes and agitated with a mini rotator (Labnet International Inc., Edison, NJ, USA) using the rocking and tumbling function at 24 rpm at 37°C for 7 days. Thereafter, the resultant cloudy solution was centrifuged at 16 000 g for 10 min. The pelleted material was resuspended in 200 lL of 10 mM phosphate buffer, pH 7.5. EM confirmed the presence of fibrils.
Electron microscopy (EM)
Samples were prepared by spotting 5 lL of a 10 lM solution on to 300-mesh carbon-coated formvar copper grids (Ted Pella, Inc., Redding, CA, USA) for 20 min at 22°C, after which excess solution was wicked away with Whatman qualitative filter paper, grade 2 (Sigma-Aldrich). The grid then was incubated with 5 lL of 2.5% (v/v) glutaraldehyde in water for 5 min and the solution wicked away as previously described. Staining was done with 5 lL of 1% (w/v) uranyl acetate in water for 3 min. The stain was wicked off and the grid was air-dried. Images were obtained using a Philips CM120 (FEI) transmission electron microscope equipped with a tungsten filament, operating at an accelerating voltage of 120 kV.
Size exclusion chromatography (SEC) SEC, peak detection, and area calculations were performed on a Waters system (Waters Corp., Milford, MA, USA) comprising a 600S controller, 616 pump, 717plus autosampler, 486 Tunable Absorbance Detector, and PeakSimple Software (Waters Corp., Milford, MA, USA). Ten microliters of 4.26 mg/mL protein in 10 mM sodium phosphate, pH 7.4, was loaded onto a 7.8 9 300 mm SRT-SEC1000 column (5-lm particle size, 100 A pore size; Sepax Technologies, Inc., Newark, DE, USA) fitted with a 7.8 9 50 mm SRT SEC-100 guard column (5-lm particle size, 100 A pore size; Sepax Technologies, Inc.). The elution was carried out isocratically with 10 mM sodium phosphate buffer, pH 7.5, at 22.5°C at a flow rate of 0.5 mL/min and monitored by UV absorbance at 280 nm. Column standardization was done using a mixture of ovalbumin (65 kDa), myoglobin (17 kDa), oxidized insulin B-chain (3.5 kDa), and vitamin B12 (1.3 kDa).
Dot blotting and PiB binding
A range of concentrations of oligomeric, protofibrillar, and fibrillar Ab, prepared in a fixed volume of 100 lL, were pipetted onto a polyvinylidene difluoride (PVDF) membrane (0.2-lm pore size) (Invitrogen, Carlsbad, CA, USA) and allowed to evaporate at 22.5°C without suction (typically requiring < 30 min). Amino acid analysis of buffer washes/eluates of the protein-blotted PVDF membrane did not show presence of protein, suggesting that most, if not all, the material blotted onto membrane remained on the membrane.
The PVDF membrane then was placed in a BD Falcon Disposable Square Integrid Petri dish (BD Biosciences, Franklin Lakes, NJ, USA) and blocked with freshly prepared 5% (w/v) dry milk solution (2 mL) for 30 min. The membranes were then washed twice with 10 mM sodium phosphate, pH 7.4, for 30 min each time. Two milliliters of 3 H-PiB (3.4 nM) then was added and the blot was incubated at 37°C for 30 min, after which the blot was washed 4 9 with 10 mM sodium phosphate buffer, pH 7.5, for 30 min each time. The membrane was air-dried overnight and then incubated in a Fujifilm BAS-TR 2025 Imaging Plate (FujiFilm, Tokyo, Japan) for 70 h along with two sets of tritium standards, 'low activity' standards with a specific activity range of 0.1-15.9 nCi/mg and 'high activity' standards with a range of 3.1-109 nCi/mg (American Radiolabeled Chemicals, Inc., St. Louis, MO, USA), and then analyzed with a Fujifilm BAS-5000 Imager (FujiFilm, Tokyo, Japan). These experiments were repeated three or more times using 3 H-PiB concentrations ranging from 0.1 to 7.5 nM (Fig. S1 ).
Results and discussion
Characterization of Ab assembly structure by transmission electron microscopy (TEM) The goal of our studies was to determine the binding specificity of PiB with respect to different biologically relevant Ab assemblies. To do so, we first prepared and characterized the structures of oligomeric, protofibrillar, and fibrillar Ab formed from Ab40 and Ab42. Protofibrillar Ab assemblies were produced using Ab40 and Ab42 containing the 'Arctic' familial AD amino acid substitution E22?G (Nilsberth et al. 2001) . This substitution produces Ab peptides with high propensities for protofibril formation, but does not appear to significantly alter protofibril or fibril structure. TEM revealed that Ab40 formed straight fibrils often comprising two twisted filaments with total width of 14.4 AE 1.6 nm and lengths greater than 1 lm (Fig. 1) . Αb42 fibrils had twisted morphologies, widths of 12.2 AE 0.8 nm, and lengths of 0.87 AE 0.43 lm.
[E22G] Ab40 samples comprised straight assemblies with widths of 10.9 AE 2.4 nm and lengths of 166.1 AE 66.9 nm. [E22G] Ab42 samples showed straight and curved assemblies 7.4 AE 1.4 nm in width and 80.9 AE 36.1 nm in length. The morphological characteristics observed were consistent with those reported previously for Arctic protofibrils (Nilsberth et al. 2001) . Low-molecular weight preparations of Ab40 or Ab42 contained no discernable assemblies. minor peaks at 20.5, 23.4, and 25.5 min (Fig. 2, solid line) . Assemblies completely excluded from the column matrix (void volume) elute at %12.5 min. The peak observed at 13.3 min, which constituted %70% of the total peak area in the chromatogram, is the protofibril peak (Walsh et al. 1999) . Peaks at 16.2 and 17.2 min, corresponding to assemblies of 15.4 and 10.5 kDa molecular mass, accounted for %4% and %20% of the peak area, respectively. These peaks likely are low-order oligomers (dimers, trimers, tetramers) that form through dissociation of protofibrils during transit through the SEC column. This dissociation is expected, according to Le Châtelier's principle (Le Châtelier 1888), because protofibrils exist in equilibrium with oligomers and fibrils (Walsh et al. 1997) . Peaks observed after 19 min correspond to UV-absorbing material too small to represent full-length Ab monomers.
[E22G]Ab42 produced a prominent peak at 13.4 min, which like the peak observed for [E22G]Ab40 at 13.3 min, corresponds to the elution time for protofibrils (Fig. 2, dotted  line) . A smaller peak eluted at 12.5 min. These two peaks constituted %37% and %47% of the total peak area in the chromatogram, respectively. The elution time of the second peak suggests that this peak also contains protofibrils, but with conformations displaying somewhat higher Stokes radii. The EM data support this suggestion, as they showed that [E22G]Ab42 produced two morphologically distinct populations of protofibrils, curved or straight. As with [E22G] Ab40, species of substantially lower size also were observed, but in substantially lower amounts (peaks at 15.9 and 16.9 min). These peaks corresponded to analytes of molecular weight 17.3 and 11.7 kDa and accounted for %4% and %6% of the total peak area, respectively. The remainder of the total peak area after 19 min (%6%) corresponds to UVabsorbing material of size too small to represent full-length Ab monomers.
Analysis of PiB-binding specificity To determine if PiB bound to oligomers or protofibrils, we dot blotted these assemblies, as well as fibrils, onto PVDF membranes. These membranes then were incubated with tritiated PiB ( 3 H-PiB), washed, and subjected to radiographic imaging (Fig. 3) . Intense signals were recorded for all Ab42 assemblies. Fibrillar Ab42 displayed the highest 3 H-PiB binding, followed by Ab42 protofibrils and then Ab42 oligomers (Fig. 3, lanes 2 , 4, and 6, respectively). Binding to Ab40 assemblies also was observed, and with the same rank order of intensities relative to assembly state (Fig. 3, lanes 1 , 3, and 5, respectively). However, for all these states, the absolute intensities were much lower than they were for Ab42. For example, at 10 lg protein loading, the intensity of Ab40 fibrils was %6-fold lower than that for Ab42 fibrils (1114 vs. 6684 arbitrary units/mm 2 ) and the intensity of Ab40 protofibrils was %13-fold lower than Ab42 protofibrils (192 vs. 2439 arbitrary units/mm 2 ). Signal intensity varied with sample loading. The data suggest that binding to fibrils saturates between 1 and 10 lg. The lowest signal intensities for both Ab40 and Ab42 fibrils were observed at 1 lg. However, we cannot determine Protein standards were albumin (65 kDa), myoglobin (17 kDa), insulin chain B (3.5 kDa), and vitamin B12 (1.3 kDa). The nominal separation range of the column is 100-100 000 Da. The void volume is %25 mL. H-PiB to Ab40 protofibrils was maximal at 30 lg, a protein load at which signal saturation had not occurred. For Ab42 protofibrils, signal intensity increased with amount of protein spotted and signal saturation occurred between 20 and 30 lg. These data show that the binding of 3 H-PiB to protofibrils, based on assembly weight, was lower than for fibrils. The lowest signal intensities were observed for stabilized Ab oligomers. Weak binding was seen at 30 lg for Ab40 oligomers. This intensity appears meaningful as no spots were observable at protein loads of 1-10 lg and a very faint spot was seen at 20 lg. A monotonic increase in signal intensity was seen for Ab42 oligomers that had not saturated at 30 lg protein loading.
These findings are significant because they reveal that 3 H-PiB not only binds fibrils but also has the capacity to bind lower order assemblies, including Arctic Ab42 protofibrils prepared in vitro and Ab42 oligomers. Relative to fibrils, the binding of 3 H-PiB for Arctic protofibrils and oligomers is progressively lower. This may explain why 11 C-PiB binding was not observed in two patients with the Arctic form of early-onset AD (Sch€ oll et al. 2012) . The conformation of protofibrils in the Arctic patients also might be different from that of Arctic protofibrils produced in vitro. In this last respect, it is relevant that the terms 'protofibrils' and 'oligomers' are generic terms referring to two populations of assemblies that have been characterized primarily on the basis of their molecular weights and gross morphologies (Teplow 2013) . Each population contains an indeterminate number of conformers, depending on the primary structure of the Ab peptides from which the assemblies form and the conditions under which assembly occurs. An extensive determination of the binding affinities of PiB using a representative subset of each population would further our understanding of PiB-binding specificity.
